ANTHRACYCLINS IN THE TREATMENT OF METASTATIC BREAST CANCERS

被引:0
|
作者
HERAIT, P
机构
来源
PATHOLOGIE BIOLOGIE | 1990年 / 38卷 / 08期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:859 / 859
页数:1
相关论文
共 50 条
  • [21] Lectin microarray profiling of metastatic breast cancers
    Fry, Simon A.
    Afrough, Babak
    Lomax-Browne, Hannah J.
    Timms, John F.
    Velentzis, Louiza S.
    Leathem, Anthony J. C.
    GLYCOBIOLOGY, 2011, 21 (08) : 1060 - 1070
  • [22] Laser immunotherapy for treatment of metastatic cancers
    Wei R.Chen
    Frontiers of Optoelectronics, 2015, 8 (04) : 465
  • [24] CONTRALATERAL BREAST CANCERS FOLLOWING TREATMENT FOR INITIAL BREAST CANCERS IN WOMEN
    PARKER, RG
    GRIMM, P
    ENSTROM, JE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03): : 213 - 216
  • [25] Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers
    Shi, Yu-Jie
    Tsang, Julia Y. S.
    Ni, Yun-Bi
    Tse, Gary M.
    ONCOLOGIST, 2017, 22 (04): : 487 - 490
  • [26] 2-N-METHYL 9-HYDROXY-ELLIPTICINE IN TREATMENT OF METASTATIC BREAST CANCERS
    ROUESSE, J
    HUERTAS, D
    SANCHOGARNIER, H
    LECHEVALIER, T
    AMIEL, JL
    BRULE, G
    TURSZ, T
    MONDESIR, JM
    BULLETIN DU CANCER, 1981, 68 (05) : 437 - 441
  • [27] Paclitaxel - An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers
    Wiseman, LR
    Spencer, CM
    DRUGS & AGING, 1998, 12 (04) : 305 - 334
  • [28] PaclitaxelAn Update of its Use in the Treatment of Metastatic Breast Cancer and Ovarian and Other Gynaecological Cancers
    Lynda R. Wiseman
    Caroline M. Spencer
    Drugs & Aging, 1998, 12 : 305 - 334
  • [29] INITIAL CHEMOTHERAPY IN NON-METASTATIC BREAST CANCERS
    CABANNE, F
    DEGISLAIN, C
    BORDES, M
    FARGEOT, P
    GUERRIN, J
    MAYER, F
    VANOLI, A
    BULLETIN DU CANCER, 1983, 70 (03) : 218 - 218
  • [30] PANVAC shows promise for metastatic breast and ovarian cancers
    Riedmann, Eva M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) : 4 - 4